GlassScriptPhysician profile
Renata Silva Starr
NPI 1730317173
$2,263.91
in general payments reported to CMS, 2019-2025
21 companies · $51.27 in 2025
The $51.27 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $132 · 2020: $89.42 · 2021: $239 · 2022: $1,023 · 2023: $97.43 · 2024: $632 · 2025: $51.27.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $613 · Education: $168.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $613.05 |
| Education | $167.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,045.00 | 2022-2025 | Truclear |
| Astellas Pharma US INC | $238.57 | 2024 | Veozah |
| Organon LLC | $187.48 | 2024 | |
| Exeltis, USA INC. | $168.71 | 2020-2025 | Slynd |
| Abbvie INC. | $157.29 | 2019-2023 | Orilissa, Lo Loestrin Fe |
| Minerva Surgical, INC | $92.02 | 2024 | |
| Aspira Women'S Health INC | $78.89 | 2021 | |
| Amgen INC. | $40.80 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $34.87 | 2021-2023 | |
| Coopersurgical, INC. | $27.76 | 2024 | Paragard T 380a |
| Myovant Sciences INC. | $23.90 | 2021 | |
| Evofem Biosciences, INC. | $23.34 | 2021 | |
| Agile Therapeutics, INC. | $22.72 | 2021 | |
| Medline Industries LP | $18.71 | 2024 | |
| Amag Pharmaceuticals, INC. | $17.67 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $17.21 | 2021 | |
| Therapeuticsmd, INC. | $16.98 | 2020 | |
| Avion Pharmaceuticals | $13.69 | 2020 | |
| Lupin INC. | $13.59 | 2021 | |
| Gynesonics, INC. | $12.99 | 2022 | |
| Mylan Pharmaceuticals INC. | $11.72 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Renata Silva Starr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.